Dabigatran etexilate Completed Phase 1 Trials for Healthy Volunteers Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03086356Study to Investigate the Pharmacokinetics (PK) and Pharmacodynamics (PD) of Idarucizumab in Chinese Healthy Male and Female Volunteers Who Had Taken Dabigatran Etexilate and Whose Plasma Concentrations of Dabigatran Were at or Close to Steady State
NCT03742336Study of PF-04965842 Effect on Dabigatran Pharmacokinetics in Healthy Participants
NCT03070171Bioequivalence of Tablet Formulation of Dabigatran Etexilate Compared to Commercial Capsule Formulation Following Oral Administration in Healthy Male Subjects
NCT02171039Relative Bioavailability of Dabigatran and Atorvastatin in Healthy Male and Female Volunteers
NCT02710630Bioavailability Study of Five Tablet Formulations of Dabigatran Etexilate Compared to Commercial Capsule Formulation in Healthy Male Subjects
NCT02171507Relative Bioavailability of Dabigatran and Diclofenac After Dabigatran Etexilate and Diclofenac Single Dose Alone or Following Concomitant Multiple Oral Administrations in Healthy Male and Female Volunteers
NCT02171559Relative Bioavailability and Pharmacodynamics of Dabigatran With Enoxaparin in Healthy Male and Female Volunteers
NCT02171533Relative Bioavailability of Single Oral Doses of Dabigatran Etexilate With or Without Oral Administration of Verapamil in Two Different Dosages in Healthy Male and Female Volunteers
NCT02171611Bioavailability of Different Applications of Dabigatran in Healthy Volunteers
NCT02171598Investigation of the Impact of Concomitant Use of Multiple Doses of Clopidogrel With Multiple Doses of Dabigatran Etexilate on the Pharmacokinetic and Pharmacodynamic Parameters in Healthy Male Subjects
NCT02171585Bioavailability of Dabigatran With or Without Clarithromycin in Healthy Volunteers
NCT02171572Single and Multiple Oral Doses of Dabigatran Etexilate in Healthy Chinese Subjects
NCT02170675Relative Bioavailability of Single Doses of Dabigatran Etexilate When Administered Alone or in Combination With a Single Dose of Ketoconazole or in Combination With q.d. Ketoconazole at Steady State in Healthy Male and Female Volunteers
NCT02171468Pharmacokinetics, Safety and Pharmacodynamics After Multiple Oral Doses of Dabigatran Etexilate Capsule in Healthy Japanese and Caucasian Male Subjects
NCT02170766Bioavailability of BIBR 953 ZW in Healthy Subjects
NCT02171442Metabolism and Pharmacokinetics of [14C]-BIBR 953 ZW After Administration of Single Doses of [14C]-BIBR 953 ZW Intravenously or [14C]-BIBR 1048 Oral Solution in Healthy Male Volunteers
NCT02171455Safety, Pharmacodynamics and Pharmacokinetics After Single Oral Administration of Dabigatran Etexilate Capsule in Healthy Subjects
NCT02171052Relative Bioavailability of Dabigatran and Digoxin in Healthy Male and Female Volunteers
NCT02171026Bioavailability of Dabigatran and Amiodarone After Multiple Oral Administrations of Dabigatran Etexilate With or Without Amiodarone as Single Dose in Healthy Male and Female Volunteers
NCT02171000Safety, Pharmacokinetics and Pharmacodynamics After Multiple Oral Doses of BIBR 1048 MS Capsule in Healthy Japanese Male Subjects
NCT02170987Assessment of Electrophysiological Effects of Dabigatran Etexilate as Single Dose on the QT Interval in Healthy Female and Male Subjects.
NCT02171624Safety and Pharmacokinetics of Quinidine Alone and in Combination With Dabigatran Etexilate
NCT02173717Relative Bioavailability of Single Doses of Dabigatran Etexilate in Healthy Volunteers
NCT02044367Relative Bioavailability of Dabigatran Capsules, Pellets and Oral Solution in Healthy Volunteers
NCT02028780Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BI 655075 (Idarucizumab) Administered Alone or With Dabigatran Etexilate in Japanese Healthy Subjects
NCT01290757Bioequivalence of Two Different Capsule Types of Dabigatran
NCT01306162Drug Interaction Study With Dabigatran Etexilate and Dronedarone in Healthy Subjects
NCT01595854Investigation of Pharmacodynamic Effects of Dabigatran and Ticagrelor and Assessment of Ticagrelor Interaction Potential With Dabigatran
NCT01734772Investigation of Drug-drug Interaction of Dabigatran and Ticagrelor
NCT01688830Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BI 655075 Administered Alone or With Dabigatran Etexilate